文献速递关节外科

比较非骨水泥型与骨水泥型初次全膝关节置换的设施成本、患者报告结局指标与翻修率:一项针对380例手术、平均随访4.3年的倾向性评分匹配患者层面价值分析

Comparing Facility Costs, Patient-Reported Outcome Measures, and Revision Rates in Cementless and Cemented Primary Total Knee Arthroplasty: Findings From a Propensity Score-Matched Patient-Level Value Analysis of 380 Procedures With a Mean 4.3-Year Follow-Up.
PubMed 文献 · J Arthroplasty · 2025-05-23

该回顾性倾向性评分匹配分析纳入76例非骨水泥型与304例骨水泥型初次全膝关节置换术,平均随访4.3年,比较设施成本、KOOS-PS评分与翻修率。非骨水泥型假体总设施成本显著更高(971 vs 800成本单位,差异+21.4%,P<0.001),KOOS-PS无显著差异,绝对价值与增量价值均显著更低,翻修率低且相似(3.9% vs 2.3%,P=0.42)。

要点

  • 非骨水泥型TKA总设施成本显著高于骨水泥型(971 vs 800成本单位,差异+21.4%,P<0.001)。
  • 两组KOOS-PS评分无显著差异,但非骨水泥型绝对价值与增量价值均显著更低。
  • 平均4.3年随访翻修率低且相似(3.9% vs 2.3%,P=0.42)。

核心结论

  • 非骨水泥型TKA在平均4.3年随访时因假体成本差异而价值更低。
  • 若观察到5年以上随访翻修率降低,或将非骨水泥型假体纳入参考定价矩阵以降低成本,非骨水泥型TKA价值提高最终是可能的。

研究设计与样本

  • 回顾性倾向性评分匹配分析,纳入76例非骨水泥型TKA与304例骨水泥型TKA,平均随访4.3年(范围1.7至8.5年)。
  • 采用时间驱动作业成本法进行成本核算,假体采用参考定价,非骨水泥型假体相对参考定价存在溢价。
  • 价值为主要结局,定义为绝对价值KOOS-PS(1年KOOS-PS与设施成本的商)与增量价值KOOS-PS(KOOS-PS变化量与设施成本的商)。
  • 翻修率也进行比较,但未纳入价值方程。

主要发现

  • 非骨水泥型TKA总设施成本显著高于骨水泥型(971 vs 800成本单位,差异+21.4%,P<0.001)。
  • 成本差异主要与非骨水泥型TKA假体成本更高有关(542 vs 367成本单位,差异+47.7%,P<0.001)。
  • KOOS-PS评分无显著差异。
  • 非骨水泥型TKA平均绝对价值KOOS-PS显著更低(48.3 vs 58.1,P<0.001)。
  • 非骨水泥型TKA平均增量价值KOOS-PS显著更低(16.5 vs 20.3,P=0.038)。

关键数值与推荐

  • 非骨水泥型TKA总设施成本971成本单位 vs 骨水泥型800成本单位(差异+21.4%,P<0.001)。
  • 非骨水泥型TKA假体成本542成本单位 vs 骨水泥型367成本单位(差异+47.7%,P<0.001)。
  • 非骨水泥型TKA绝对价值KOOS-PS 48.3 vs 骨水泥型58.1(P<0.001)。
  • 非骨水泥型TKA增量价值KOOS-PS 16.5 vs 骨水泥型20.3(P=0.038)。
  • 非骨水泥型TKA翻修率3.9% vs 骨水泥型2.3%(P=0.42)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Health care value accounts for clinical outcomes and cost. A methodology for more accurate cost accounting is time-driven activity-based costing. No prior study has evaluated the value of cementless total knee arthroplasty (TKA) using time-driven activity-based costing. METHODS: We performed a retrospective propensity score-matched analysis of 76 cementless TKAs and 304 cemented TKAs with a mean follow-up of 4.3 years (range, 1.7 to 8.5). Reference pricing for implants was used, and cementless implants were available at a premium price relative to reference pricing. Value was the primary outcome and was defined twofold: Absolute Value KOOS-PS was the quotient of 1-year Knee Osteoarthritis Outcome Score-Physical Function Short-Form (KOOS-PS) and facility cost; Incremental Value KOOS-PS was the quotient of delta KOOS-PS and facility cost. Revision rate was also compared but not factored into our value equation. RESULTS: Cementless TKAs had significantly higher total facility costs than cemented TKAs (971 versus 800 cost units; percent difference: +21.4%; P < 0.001). The cost difference was principally related to cementless TKAs having higher implant costs (542 versus 367 cost units; percent difference: +47.7%; P < 0.001). There were no significant differences in KOOS-PS scores. Cementless TKA was found to have significantly reduced mean Absolute Value KOOS-PS (48.3 versus 58.1; P < 0.001) and Incremental Value KOOS-PS (16.5 versus 20.3; P = 0.038). The revision rate at the mean 4.3-year follow-up was low and similar (3.9 versus 2.3%; P = 0.42). CONCLUSIONS: We compared value (defined as 1-year patient-reported outcome measures relative to facility costs) between cementless and cemented TKA. Cementless TKAs demonstrate lower value at a mean 4.3-year follow-up due to differences in implant cost. Increased value for cementless TKA is ultimately plausible if reductions in revision rates beyond 5-year follow-up are observed or if cementless TKA implants are incorporated in reference pricing matrices to reduce their cost.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Peterson SL, Sauder N, Meghpara MM, et al. Comparing Facility Costs, Patient-Reported Outcome Measures, and Revision Rates in Cementless and Cemented Primary Total Knee Arthroplasty: Findings From a Propensity Score-Matched Patient-Level Value Analysis of 380 Procedures With a Mean 4.3-Year Follow-Up. J Arthroplasty. 2025. PMID: 40414369. doi:10.1016/j.arth.2025.05.067

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。